Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Rubraca (rucaparib) for the Treatment of Advanced Ovarian Cancer

Drug (Brand / Generic)

Rubraca / rucaparib

Developer

Clovis Oncology

Product Description

PARP inhibitor

Current Indication

Ovarian cancer

Market Sector

Oncology

Development Status

Approved in the US
Expand

Go Top